<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35308589</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2451-9936</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of ophthalmology case reports</Title>
          <ISOAbbreviation>Am J Ophthalmol Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Challenges in the management of bilateral eyelid closure in Stevens-Johnson Syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>101473</StartPage>
          <MedlinePgn>101473</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">101473</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajoc.2022.101473</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">To describe the challenges of surgically treating Stevens-Johnson syndrome (SJS) cases with bilateral eyelid closure, a serious ocular sequela.</AbstractText>
          <AbstractText Label="OBSERVATIONS" NlmCategory="UNASSIGNED">This study involved two 69-year-old females, with subacute-stage SJS (Case 1 and Case 2), and a 37-year-old male with chronic-stage SJS (Case 3). Case 1 had undergone simultaneous bilateral symblepharon lysis at 4-months post SJS onset, and her logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (VA) (BCVA) improved from 2.8 (both eyes) to 0.7 OD and 0.4 OS. Cases 2 and 3 underwent symblepharon lysis with intraoperative use of mitomycin C (MMC) and amniotic membrane transplantation (AMT) at 9 months (OD) and 11 months (OS) (Case 2) and at 31 years (OD) (Case 3) post SJS onset. At 3-months postoperative, Case 3 underwent cultivated oral mucosal epithelial sheet transplantation (COMET). In both cases, BCVA (logMAR) improved with the postoperative use of limbal-rigid contact lenses (CLs); i.e., from 2.8 to 0.5 OD and 1.2 OS (Case 2) and from 2.8 to 1.1 OD (Case 3). In all 5 treated eyes, eyelid opening and VA were maintained through final follow-up.</AbstractText>
          <AbstractText Label="CONCLUSION AND IMPORTANCE" NlmCategory="UNASSIGNED">In severe bilateral symblepharon cases, it can be difficult to predict postoperative outcomes, as proper surgical treatment is often delayed. In SJS cases with bilateral eyelid closure, the surgical intervention strategy of AMT and COMET, combined with limbal-rigid CL wear post surgery, can result in improved vision, and symblepharon surgery might be easier and possibly result in a better prognosis when performed at the early phase.</AbstractText>
          <CopyrightInformation>© 2022 Published by Elsevier Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Aziza</LastName>
            <ForeName>Yulia</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harada</LastName>
            <ForeName>Kohei</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ueta</LastName>
            <ForeName>Mayumi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fukuoka</LastName>
            <ForeName>Hideki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kinoshita</LastName>
            <ForeName>Shigeru</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sotozono</LastName>
            <ForeName>Chie</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Ophthalmol Case Rep</MedlineTA>
        <NlmUniqueID>101679941</NlmUniqueID>
        <ISSNLinking>2451-9936</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Amniotic membrane transplantation (AMT)</Keyword>
        <Keyword MajorTopicYN="N">Cultivated oral mucosal epithelial sheet transplantation (COMET)</Keyword>
        <Keyword MajorTopicYN="N">Improvement of visual acuity</Keyword>
        <Keyword MajorTopicYN="N">Severe symblepharon</Keyword>
      </KeywordList>
      <CoiStatement>The following authors have no financial disclosures: YA, KH, MU, HF, SK, CS.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>21</Day>
          <Hour>8</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35308589</ArticleId>
        <ArticleId IdType="pmc">PMC8924635</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajoc.2022.101473</ArticleId>
        <ArticleId IdType="pii">S2451-9936(22)00219-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Harr T., French L.E. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3018455</ArticleId>
            <ArticleId IdType="pubmed">21162721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwartz R.A., McDonough P.H., Lee B.W. Toxic epidermal necrolysis: part I. introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013;69(2):173. e1-13;quiz 85-86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23866878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bastuji-Garin S., Rzany B., Stern R.S., Shear N.H., Naldi L., Roujeau J.-C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8420497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain R., Sharma N., Basu S., et al.  Stevens-Johnson syndrome: the role of an ophthalmologist. Surv Ophthalmol. 2016;61(4):369–399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26829569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kohanim S., Palioura S., Saeed H.N., et al.  Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis – comprehensive review and guide to therapy. II. Ophthalmic disease. Ocul Surf. 2016;14(20):168–188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26882981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang L., Sheha H., Li J., et al.  Limbal stem cell transplantation: new progresses and challenges. Eye. 2009;23(10):1946–1953.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2853891</ArticleId>
            <ArticleId IdType="pubmed">19098704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deng S.X., Sejpal K.D., Tang Q. Characterization of limbal stem cell deficiency by in vivo laser scanning confocal microscopy a microstructural approach. Arch Ophthalmol. 2012;130(4):440–445.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3928362</ArticleId>
            <ArticleId IdType="pubmed">22159172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puangsricharern V., Tseng S.C.G. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 1995;102(10):1476–1485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9097795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshikawa Y., Ueta M., Fukuoka H., et al.  Long-term progression of ocular surface disease in Stevens-Johnson syndrome and toxic epidermal necrolysis. Cornea. 2020;39(6):745–753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32028281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Academy of Ophthalmology . American Academy of Ophthalmology. Orbit, Eyelids, and Lacrimal System, Section 7, Basic and Clinical Science Course. American Academy of Ophthalmology; San Francisco, CA: 2017. Classification and management of eyelid disorders; pp. 155–195.</Citation>
        </Reference>
        <Reference>
          <Citation>Jain S., Rastogi A. Evaluation of the outcome of amniotic membrane transplantation for ocular surface reconstruction in symblepharon. Eye. 2004;18(12):1251–1257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15184952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao D., Yin H.Y., Cheng A., Chen R., Sheha H., Tseng S.C.G. Sealing of the gap between the conjunctiva and tenon capsule to improve symblepharon surgery. Am J Ophthalmol. 2015;160(3):438–446. e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26093286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kheirkhah A., Blanco G., Casas V., Hayashida Y., Raju V.K., Tseng S.C.G. Surgical strategies for fornix reconstruction based on symblepharon severity. Am J Ophthalmol. 2008;146(2):266–275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18514608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iyer G., Srinivasan B., Agarwal S., et al.  Treatment modalities and clinical outcomes in ocular sequelae of Stevens-Johnson syndrome over 25 years – a paradigm shift. Cornea. 2016;35(1):46–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26555585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shanbhag S.S., Singh S., Koshy P.G., et al.  A beginner's guide to mucous membrane grafting for lid margin keratinization: review of indications, surgical technique and clinical outcomes. Indian J Ophthalmol. 2021;69:794–805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8012968</ArticleId>
            <ArticleId IdType="pubmed">33727438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dogru M., Tsubota K. Current concepts in ocular surface reconstruction. Semin Ophthalmol. 2005;20(2):75–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16020348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomes J.A.P., Santos M.S., Ventura Â.S., et al.  Amniotic membrane with living related corneal limbal/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome. Arch Ophthalmol. 2003;121(10):1369–1374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14557171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee R., Khoueir Z., Tsikata E., et al.  Long-term visual outcomes and complications of Boston keratoprosthesis type II implantation. Ophthalmology. 2017;124(1):27–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27538795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espana E.M., Pascuale M.D., Grueterich M., Solomon A., Tseng S.C.G. Keratolimbal allograft in corneal reconstruction. Eye. 2004;18:406–417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15069439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das J.K., Mehdi J., Chakravarty R., Soibam R. Mucous membrane grafting for the post-Steven-Johnson syndrome symblepharon: a case report. Indian J Ophthalmol. 2011;59(3):231–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3120246</ArticleId>
            <ArticleId IdType="pubmed">21586847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotozono C., Inatomi T., Nakamura T., et al.  Visual improvement after cultivated oral mucosal epithelial transplantation. Ophthalmology. 2013;120(1):193–200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23084239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venugopal R., Nagpal R., Mohanty S., et al.  Outcomes of cultivated oral mucosal epithelial transplantation in eyes with chronic Stevens-Johnson syndrome sequelae. Am J Ophthalmol. 2021;222:82–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32818447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gopakumar V., Agarwal S., Srinivasan B., et al.  Clinical outcome of autologous cultivated oral mucosal epithelial transplantation in ocular surface reconstruction. Cornea. 2019;38(10):1273–1279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31356413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotozono C., Yamauchi N., Maeda S., et al.  Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis. Am J Ophthalmol. 2014;158:983–993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25036881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoi M., Ueta M., Ogino K., et al.  Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome/toxic epidermal necrolysis. Contact Lens Anterior Eye. 2020;43(6):535–542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32513522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papakostas T.D., Le H.G., Chodosh J., et al.  Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis. Ophthalmology. 2015;122(2):248–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25282251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heur M., Bach D., Theophanous C., et al.  Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome. Am J Ophthalmol. 2014;158(1):49–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24699156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Rao R., Jacobs D.S., et al.  Prosthetic replacement of the ocular surface ecosystem treatment for ocular surface disease in pediatric patients wth Stevens-Johnson syndrome. Am J Ophthalmol. 2019;201:1–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6532769</ArticleId>
            <ArticleId IdType="pubmed">30664843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aziza Y., Inatomi T., Sotozono C., Kinoshita S. Pterygium excision with modified bare sclera technique combined with mitomycin C. Jpn J Ophthalmol. 2021;65(1):89–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33205316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saif A.T.S., Khalek M.O.A., Mahran W.M. Role of amniotic membrane transplantation in symblepharon. JOJ Ophthal. 2016;1(3):555–565.</Citation>
        </Reference>
        <Reference>
          <Citation>Jain S., Rastogi A. Evaluation of the outcome of amniotic membrane transplantation for ocular surface reconstruction in symblepharon. Eye. 2004;18(12):1251–1257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15184952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tseng S.C.G., Di Pascuale M.A., Liu D.T., Gao Y.Y., Baradaran-Rafii A. Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology. 2005;112(5):896–903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15878073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimazaki J., Shinozaki N., Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with pterygium. Br J Ophthalmol. 1998;82(3):235–240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1722509</ArticleId>
            <ArticleId IdType="pubmed">9602618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honavar S.G., Bansal A.K., Sangwan V.S., Rao G.N. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology. 2000;107(5):975–979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10811093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh P., Singh A. Mitomycin-C use in ophthalmology. IOSR J Pharm. 2013;3(1):12–14.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsubota K., Satake Y., Ohyama M., et al.  Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122(1):38–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8659597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rootman D.B., Kim M.J., Aldave A.J. Ocular surface, fornix, and eyelid rehabilitation in Boston type I keratoprosthesis patients with mucous membrane disease. Ophthalmic Plast Reconstr Surg. 2015;31(1):43–49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24911535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu Y., Liu J., Tseng S.C.G. Oral mucosal graft to correct lid margin pathologic features in cicatricial ocular surface diseases. Am J Ophthalmol. 2011;152(4):600–608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21683334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thoft R.A. Keratoepithelioplasty. Am J Ophthalmol. 1984;97(1):1–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6364814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee W.B., Mannis M.J.  In: Ocular Surface Disease: Cornea, Conjunctiva and Tear Film. Holland E.J., Mannis M.J., Lee W.B., editors. Elsevier; Philadelphia, PA: 2013. Historical concepts of ocular surface disease; pp. 3–10.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakamura T., Takeda K., Inatomi T., Sotozono C., Kinoshita S. Long-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders. Br J Ophthalmol. 2011;95(7):942–946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21097786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura T., Inatomi T., Sotozono C., et al.  Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br J Ophthalmol. 2004;88(10):1280–1284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1772364</ArticleId>
            <ArticleId IdType="pubmed">15377551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotozono C., Inatomi T., Nakamura T., et al.  Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity. Acta Ophthalmol. 2014;92(6):e447–453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4329382</ArticleId>
            <ArticleId IdType="pubmed">24835597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Komai S., Inatomi T., Nakamura T., et al.  Long-term outcome of cultivated oral mucosal epithelial transplantation for fornix reconstruction in chronic cicatrizing diseases. Br J Ophthalmol. 2021;0:1–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34006509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotozono C., Inatomi T., Nakamura T., et al.  Oral mucosal epithelial transplantation and limbal-rigid contact lens: a therapeutic modality for the treatment of severe ocular surface disorders. Cornea. 2020;39(11):S19–S27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33181721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shanbhag S.S., Patel C.N., Goyal R., Donthineni P.R., Singh V., Basu S. Simple limbal epithelial transplantation (SLET): review of indications, surgical technique, mechanism, outcomes, limitations, and impact. Indian J Ophthalmol. 2019 Aug;67(8):1265–1277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6677059</ArticleId>
            <ArticleId IdType="pubmed">31332106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y., Lu X.Y., Hu R.J. Evaluation of artificial tears on cornea epithelium healing. Int J Ophthalmol. 2018;11(7):1096–1101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6048335</ArticleId>
            <ArticleId IdType="pubmed">30046523</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
